VNRX•prnewswire•
Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation
Summary
Showing New Indication for Nu.Q® NETs HENDERSON, Nev., Feb. 4, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the sponsorship of a symposium at the European Hidradenitis Suppurativa Foundation (EHSF) Conference...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 4, 2026 by prnewswire